PG | Weekly | Haru Insights

Procter & Gamble’s CEO, Shailesh Jejurikar, executed an unexplained insider sale of 6,176 shares for $888,047, triggering investor concern amid ongoing stock underperformance and a widening gap with peers like Coca-Cola and Colgate-Palmolive.
PG’s Q2 earnings report, while delivering a margin beat and solid free cash flow, was marred by a missed revenue forecast and tepid full-year EPS guidance, sparking a 2.3% post-earnings decline and deepening skepticism about its growth trajectory.

PG’s unbroken 70-year streak of dividend increases remains a defining benchmark in corporate reliability, reinforcing its identity as a true dividend aristocrat and a trusted anchor for long-term income investors.
The bold transformation of Olay into science-driven, holistic skincare—evidenced by the innovative Barrier Bootcamp campaign and expansion into body care—positions the brand at the forefront of Gen Z and millennial wellness trends.
PG’s margin beat in Q2 underscores strong operational discipline, proving the company can maintain profitability even amid rising inflation and input cost pressures.
Free cash flow generation remains robust, highlighting the resilience of PG’s core business model and its ability to fund dividends, share buybacks, and strategic reinvestment.
The sustained premium brand portfolio, now fortified by modernized skincare and beauty offerings, signals a credible shift toward innovation without sacrificing legacy strength.

The Procter & Gamble Company (PG)[Tv]